miR-215 promotes malignant progression of gastric cancer by targeting RUNX1

por Li, Na, Zhang, Qi-Yue, Zou, Jian-Ling, Li, Zhong-Wu, Tian, Tian-Tian, Dong, Bin, Liu, Xi-Juan, Ge, Sai, Zhu, Yan, Gao, Jing, Shen, Lin
Publicado 2015

XELOX doublet regimen versus EOX triplet regimen as first‐line treatment for advanced gastric cancer: An open‐labeled, multicenter, randomized, prospective phase III trial (EXELOX)...

por Zhu, Xiao‐Dong, Huang, Ming‐Zhu, Wang, Yu‐Sheng, Feng, Wan‐Jing, Chen, Zhi‐Yu, He, Yi‐Fu, Zhang, Xiao‐Wei, Liu, Xin, Wang, Chen‐Chen, Zhang, Wen, Ying, Jie‐Er, Wu, Jun, Yang, Lei, Qin, Yan‐Ru, Luo, Jian‐Feng, Zhao, Xiao‐Ying, Li, Wen‐Hua, Zhang, Zhe, Qiu, Li‐Xin, Geng, Qi‐Rong, Zou, Jian‐Ling, Zhang, Jie‐Yun, Zheng, Hong, Song, Xue‐Feng, Wu, Shu‐Sheng, Zhang, Cheng‐Yan, Gong, Zhe, Liu, Qin‐Qin, Wang, Xiao‐Feng, Xu, Qi, Wang, Qi, Ji, Jian‐Mei, Zhao, Jian, Guo, Wei‐Jian
Publicado 2022